Also trades as: VM.V (TSXV) · $vol 0M
VYYRF OTC
Voyageur Pharmaceuticals Ltd.
1W: -7.4%
1M: -19.4%
3M: +5.3%
YTD: -23.1%
1Y: -16.7%
3Y: +94.2%
5Y: +149.4%
$0.10
+0.00 (+0.00%)
Weekly Expected Move ±581.3%
$-1
$-0
$0
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$3M
-855.9% ▼
Capital Expenditures
$6
+100.0% ▲
5Y CAGR: -87.2%
Free Cash Flow
-$3M
-855.9% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$102K
-37.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | -$2M | -$1M | -$2M | -$4M |
| Depreciation & Amort. | $2K | $9K | $2K | $2K | $1K |
| Stock-Based Comp. | $738K | $207K | $234K | $467K | $0 |
| Change in Working Capital | -$343K | -$244K | $110K | $927K | -$171K |
| Other Non-Cash Items | $0 | $56K | $62K | $9K | $809K |
| Operating Cash Flow | -$2M | -$2M | -$991K | -$302K | -$3M |
| — Investing Activities — | |||||
| Capital Expenditures | -$432K | -$283K | -$175K | $0 | -$270K |
| Acquisitions (Net) | $0 | $9K | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$438K | -$283K | -$175K | -$166K | $0 |
| Investing Cash Flow | -$432K | -$274K | -$175K | -$166K | -$270K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$19K | -$17K | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $610K | -$18K | -$63K | -$24K | $0 |
| Financing Cash Flow | $3M | $1M | $1M | $632K | $3M |
| Net Change in Cash | $810K | -$781K | -$29K | $163K | $102K |
| Cash End of Period | $813K | $32K | $2K | $166K | $267K |
| Free Cash Flow | -$2M | -$2M | -$991K | -$302K | -$3M |